Cargando…
Gut-Homing Conventional Plasmablasts and CD27(−) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans
Currently, there is no licensed Shigella vaccine; however, various promising live-attenuated vaccine candidates have emerged, including CVD1208S (ΔguaBA, Δset, Δsen S. flexneri 2a), which was shown to be safe and immunogenic in Phase 1 clinical trials. Here, we report the immune responses elicited i...
Autores principales: | Toapanta, Franklin R., Simon, Jakub K., Barry, Eileen M., Pasetti, Marcela F., Levine, Myron M., Kotloff, Karen L., Sztein, Marcelo B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138503/ https://www.ncbi.nlm.nih.gov/pubmed/25191323 http://dx.doi.org/10.3389/fimmu.2014.00374 |
Ejemplares similares
-
T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans
por: Toapanta, Franklin R., et al.
Publicado: (2018) -
Plasmablastic plasma cell myeloma mimicking plasmablastic lymphoma
por: Choi, Qute, et al.
Publicado: (2010) -
Plasmablastic lymphoma in Malawi
por: Zuze, Takondwa, et al.
Publicado: (2018) -
Orbital plasmablastic lymphoma
por: Bloch, Edward, et al.
Publicado: (2017) -
Plasmablastic lymphoma: An update
por: Bailly, Jenique, et al.
Publicado: (2022)